<DOC>
	<DOC>NCT02690467</DOC>
	<brief_summary>The purpose of this study is to determine the non-inferiority of a new Pic Insupen 34Gx3,5mm needle vs. a 32Gx4mm needle in terms of metabolic control, safety and acceptability in patients with diabetes treated with insulin.</brief_summary>
	<brief_title>Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Patients with type 1 or type 2 diabetes Age &gt;= 18 years Multiple daily injections of insulin for at least 6 months Signed informed consent Pregnancy or or breast feeding Inability to fill in the questionnaire Combined therapy for diabetes (oral drugs associated with insulin injections) Any medical condition that could interfere with the study according to the investigator's opinion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Insulin therapy</keyword>
	<keyword>Needle</keyword>
</DOC>